Identifying mutations in epilepsy patients helps prevent sudden unexpected death, and iPSC technology may guide the development of mutation-specific precision medicine for inherited arrhythmias.
Identifying mutations and providing optimal therapy in patients with epilepsy and inherited arrhythmia syndromes may help prevent sudden unexpected death in epilepsy, with iPSC technology offering novel pathophysiological insights.
Absolute Event Rate: 0% vs 0%
mutations in patients with epilepsy and providing optimal therapy will help prevent sudden unexpected death in epilepsy. Further studies using the iPSC technology may provide novel insights into the pathophysiology of atypical clinical phenotypes of IASs and the development of mutation-specific precision medicine.
Nakajima et al. (Sat,) reported a other. Identifying mutations in epilepsy patients helps prevent sudden unexpected death, and iPSC technology may guide the development of mutation-specific precision medicine for inherited arrhythmias.